We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
[Effect of GBE50 on experimental arrhythmias].
Zhongguo Zhong Yao za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 2010 January
OBJECTIVE: The action and mechanism of ginkgo leaf extract (EGB50) in fighting arrhythmia were studies.
METHOD: The animal model of arrhythmia was established by intravenous drip of aconitine and ouabain, and the standard microelectrode technique was used.
RESULT: In Oua model, threshold doses of ouabain induced VP, VT, VF, CA were observed. GBE50 significantly increased threshold doses of ouabain. In Aco model, threshold doses of Aco induced VP, VT, VF, CA were observed, GBE50 significantly increased threshold doses of Aco. Effects of GBE50 on delayed afterdepolarization and triggered activity induced by ouabain in guinea pig papillary muscles DADs and TA were markedly suppressed by GBE50. The amplitude and duration of DADs were reduced by GBE50 (50 mg x L(-1)) from (13.25 +/- 2.38) mV and (198.38 +/- 53.62) ms to (4.04 +/- 1.44) mV and (57.00 +/- 18.62) ms, respectively, and the induced time of DADs was prolonged from (12.37 +/- 2.26) to (23.00 +/- 4.00) min. TA was reduced from 87.5% to 16.67% (P<0.05, P<0.01). GBE50 (2,10 mmol x L(-1)) had significant therapeutic effects on DADs. The amplitude and duration of DADs were reduced to (10.41 +/- 3.06) mV, (8.92 +/- 2.68) mV and (128.33 +/- 18.91) ms, 103.33 +/- 20.64 ms (P<0.05, P <0. 01 vs control).
CONCLUSION: GBE50 can fight arrhythmia following aconitine and ouabain. GBE50 has inhibitory effects on DADs and TA induced by ouabain and high Ca2+ in guinea pig papillary muscles.
METHOD: The animal model of arrhythmia was established by intravenous drip of aconitine and ouabain, and the standard microelectrode technique was used.
RESULT: In Oua model, threshold doses of ouabain induced VP, VT, VF, CA were observed. GBE50 significantly increased threshold doses of ouabain. In Aco model, threshold doses of Aco induced VP, VT, VF, CA were observed, GBE50 significantly increased threshold doses of Aco. Effects of GBE50 on delayed afterdepolarization and triggered activity induced by ouabain in guinea pig papillary muscles DADs and TA were markedly suppressed by GBE50. The amplitude and duration of DADs were reduced by GBE50 (50 mg x L(-1)) from (13.25 +/- 2.38) mV and (198.38 +/- 53.62) ms to (4.04 +/- 1.44) mV and (57.00 +/- 18.62) ms, respectively, and the induced time of DADs was prolonged from (12.37 +/- 2.26) to (23.00 +/- 4.00) min. TA was reduced from 87.5% to 16.67% (P<0.05, P<0.01). GBE50 (2,10 mmol x L(-1)) had significant therapeutic effects on DADs. The amplitude and duration of DADs were reduced to (10.41 +/- 3.06) mV, (8.92 +/- 2.68) mV and (128.33 +/- 18.91) ms, 103.33 +/- 20.64 ms (P<0.05, P <0. 01 vs control).
CONCLUSION: GBE50 can fight arrhythmia following aconitine and ouabain. GBE50 has inhibitory effects on DADs and TA induced by ouabain and high Ca2+ in guinea pig papillary muscles.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app